| Subject: | FDA Issues Public Health Advisory Regarding Levemir Insulin |
| Category: | Food and Drug Administration (FDA)
|
| Published: | Mon, 15 Jun 2009 - 09:00 am |
| The Food and Drug Administration (FDA) has issued a Public Health Advisory regarding Levemir, made by Novo Nordisk Inc. According to the FDA, some stolen vials of the long-acting insulin Levemir are being sold in the U.S. market and may not have been stored and handled properly, and may be dangerous for patients to use. Three lots or a total of 129,000 vials of this product were stolen in all. The FDA is advising patients who use Levemir insulin to: Check personal supplies of... The full article is available to StayAlert subscribers. Click here for a free trial subscription. |
|
RESOURCES:
External Links:
|
|
StayAlert! provides immediate online healthcare compliance validation to our healthcare users. When faced with dramatic reductions in healthcare dollars, StayAlert! focuses on those processes that can save the most time and money. By automating labor-intensive activities, StayAlert! almost instantly produces a positive impact on the healthcare user's bottom line. The policies alone included with the StayAlert! notices can save you $65,000 or more in labor costs each year. Organizations will realize dramatic cost savings through elimination of labor intensity, increased productivity with the benefit of ensuring regulatory compliance. StayAlert! is the service-oriented supplier of health care's compliance needs. The StayAlert! system was designed by healthcare professionals actively working in the healthcare environment, who were faced with attempting to competently provide quality care and services while "doing more with less". StayAlert! provides the answer to efficiently performing a variety of required job components from one centralized virtual location. StayAlert! improves data sharing and communications, thus reducing cost, broadening access and providing a system of documentation and follow-up. |
|